Tags: Biomarkers

announcements

The ADDF Announces New Research Initiative to Advance Digital Tools for Detection for Alzheimer's

The ADDF's Diagnostics Accelerator is seeking to fund the development of digital tools to capture quantifiable biomarkers.

blog

Top 5 Advances in 2018

In 2018 we have seen increased investments in Alzheimer's biomarkers and increased interest in prevention.

blog

Leading Scientists Share Exciting Research Developments at the ADDF Fall Symposium

At the ADDF's Ninth Annual Fall Symposium, Richard S. Isaacson, Michelle M. Mielke, and Mark A. Mintun discussed Alzheimer's biomarkers and prevention.

blog

Two Decades of Research: The ADDF's 19th International Conference on Alzheimer’s Drug Discovery

Researchers shared updates on their approaches to developing Alzheimer's treatments at our annual conference.

announcements

19th International Conference on Alzheimer's Drug Discovery Highlights Multiple Approaches

The conference, organized by the Alzheimer's Drug Discovery Foundation, focused on gene therapy and alternative modalities for neurodegenerative diseases, progress in developing novel drugs, as well as the need for new biomarkers.

announcements

$2.3 Million in New Funding Focused on Novel Biomarkers and Treatments

The Alzheimer's Drug Discovery Foundation (ADDF) announces funding for a novel biomarker and two Phase I clinical studies.

blog

Top Five Highlights from AAIC 2018

The ADDF looks back at the 2018 Alzheimer's Association International Conference.

announcements

New Coalition of Philanthropists Including Bill Gates, Leonard Lauder Commit More Than $30 Million

Bill Gates and Leonard Lauder have announced Diagnostics Accelerator, an initiative to develop new biomarkers for early detection for Alzheimer's.

announcements

$2.5 Million in New Funding Exemplifies ADDF’s Strategy

We announce $2.5 million in new funding, which reflects the comprehensive nature of our strategy to prevent and treat Alzheimer’s disease.